Addressing medicine shortages is a top priority in 2020 for the WHO, the EMA and the OECD. In this white paper, we analyse reported shortages in Q4 2019 (prior to COVID-19) across 11 representative European countries and provide new insight on the nature of shortages in Europe.

Key analyses include:

• Shortage reporting definition analysis
• Comparison of active shortages across 11 countries
• Molecules in shortage by number of countries
• Breakdown of shortages by protection status
• Number of molecules in shortage by company size